# The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions

> **NCT07055048** · — · NOT_YET_RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Liver Cancer, Adult

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07055048
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07055048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07055048, "The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07055048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*